Revisiting the Rehabilitation Act

By Carol Glazer and Jesse Fryburg, National Organization on Disability

1973 was a momentous year in the United States. The Supreme Court overturned states’ bans on abortion with Roe v. Wade. The Vietnam War ended. Secretariat became the first Triple Crown winner in 25 years. Homosexuality was removed as a disorder from the DSM-II.

Largely lost in the annals of 1973, however, is the poorly-named Rehabilitation Act, which among other things prevents the federal government and its contractors from discriminating against individuals with disabilities in hiring. The goal: put Americans with disabilities to work.

How did such a seemingly significant civil rights legislation become an historical footnote It may not have been hair-raising like Secretariat, nor as controversial as Roe. But the bill had the potential to impact millions of people and should have created more than a few ripples on the horizon of social notice. Perhaps it has been overshadowed by the subsequent, more sweeping Americans with Disabilities Act (ADA), but that doesn’t tell the whole story.

At its core, the Rehab Act was a sprinkler where a firehose was needed: well-intentioned but lacking power. It proffered a narrow, subjective definition of “disability,” and despite making disability a protected class, did not prescribe mechanisms for enforcing those protections. As a result, the Act has not meaningfully impacted employment rates for Americans with disabilities.

But the foundation of the bill was strong. So disability organizations including the National Organization on Disability worked with the Obama Administration to shore it up.

The revised law, signed in 2014, built upon the expanded, more inclusive definition of “disability” established by the ADA Amendments Act (2008). It instituted a workforce disability goal of 7% for all federal contractors, and compelled them to invite job applicants to voluntarily disclose their disabilities. Additionally, the law required contractors to show progress in meeting the disability hiring goals, translating the law’s aspirations into actual action.

There remain challenges, however, foremost among which: the new rules have gone largely unenforced due to a lack of compliance audits. According to the Government Accountability Office, 85% of required federal contractors do not have affirmative action plans (the basis for the audits).

Enter an unlikely enforcer, stage left: The Trump Administration. Craig Leen, Acting Director of the Office of Federal Contract Compliance Programs (OFCCP), which enforces such regulations, recently announced that OFCCP is planning to conduct 500 “focused reviews” or audits of disability practices alone, in 2019, the largest effort of its type in recent memory. At long last, five years after the 503 rule change was signed, firms will be held accountable for living up to the letter and spirit of the law.

For generations, persons with disabilities have been an asset to American industry, and offered companies talent, creativity, and grit. They have helped companies tap the $500B+ disability consumer market and been drivers of innovation; from curb cuts in sidewalks to touch screens on iPhones.

If all of these carrots haven’t compelled a closer look at candidates with disabilities, look out: the stick is coming.

Latest News

What Friends Tell Friends: Choose Kaiser Permanente

Originally published on Integrated, nonprofit health plan tops NICE Satmetrix customer experience benchmark study for 10th straight year. For the 10th year in a row, more people would recommend Kaiser Permanente to a friend or colleague than any other health plan in the nation, according to the recently released…

Cesar Conde

NBCUniversal Sets Ambitious 50% Diversity Goal for Women, People of Color

Cesar Conde, chairman at NBCUniversal News Group, announced a groundbreaking goal to have a 50% diverse workforce at NBCUniversal, according to Deadline. Conde, the first Latino in this role, outlined his plans in an internal video for employees on Wednesday. The ultimate goal is for NBCUniversal, No. 7 on DiversityInc’s 2020…

Mastercard Expands to the U.S. & Canada, Delivering a Search Tool That Identifies What Stores Near You Are Open for Business

Originally published on Search solution complements new Digital Acceleration for Small Business global initiative which helps small businesses advance digitally and drive online commerce As businesses seek to draw customers back both in store and online, Mastercard is introducing new tools to support them. Today, Mastercard announced the geographic…

TIAA Launches Programs to Raise Awareness of Racial Injustice and Support Communities in Need through the “Be The Change” Initiative

On June 30, TIAA announced new virtual programs designed to raise awareness of racial injustice and support communities in need as a part of the company’s recently launched “Be the Change” initiative. One is TIAA’s “Race Against Racism,” an effort in support of The Innocence Project which included more than…

Stop TB Partnership and Johnson & Johnson, with support from USAID and The Global Fund, Announce Price Reduction for SIRTURO® (bedaquiline) for Treatment of Drug-Resistant Tuberculosis in Low- and Middle-Income Countries

Originally published on Joint efforts aim to accelerate scale-up of WHO-recommended all-oral treatment regimens – a transition urgently needed to help protect the health of people with drug resistant-tuberculosis who are particularly vulnerable during COVID-19 pandemic In 2020, the initiative aims to reach at least 125,000 patients and could…

Toyota, Alabama A&M and Huntsville Hospital Collaborate to Make COVID-19 Testing Easier

Originally published on $100,000 grant provides free service to the community Alabama A & M University (AAMU), Huntsville Hospital and Toyota are developing a mobile health clinic initiative to provide free COVID-19 testing to underserved communities in Madison County. Launching later this year, the mobile medical clinic program has…

Sanofi and Regeneron Provide Update on Kevzara® (sarilumab) Phase 3 U.S. Trial in COVID-19 Patients

Originally published on Sanofi and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Phase 3 trial of Kevzara® (sarilumab) 400 mg in COVID-19 patients requiring mechanical ventilation did not meet its primary and key secondary endpoints when Kevzara was added to best supportive care compared to best supportive care alone (placebo)….